Evogene Debt to Equity Ratio 2012-2024 | EVGN

Current and historical debt to equity ratio values for Evogene (EVGN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Evogene debt/equity for the three months ending March 31, 2024 was 0.00.
Evogene Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $0.02B $0.03B 0.84
2023-12-31 $0.02B $0.03B 0.78
2023-09-30 $0.02B $0.04B 0.61
2023-06-30 $0.02B $0.03B 0.72
2023-03-31 $0.02B $0.03B 0.74
2022-12-31 $0.02B $0.04B 0.61
2022-09-30 $0.02B $0.04B 0.55
2022-06-30 $0.01B $0.05B 0.25
2022-03-31 $0.01B $0.06B 0.22
2021-12-31 $0.01B $0.06B 0.20
2021-09-30 $0.01B $0.07B 0.18
2021-06-30 $0.01B $0.08B 0.14
2021-03-31 $0.01B $0.08B 0.13
2020-12-31 $0.02B $0.06B 0.26
2020-09-30 $0.01B $0.06B 0.18
2020-06-30 $0.01B $0.05B 0.20
2020-03-31 $0.01B $0.06B 0.18
2019-12-31 $0.01B $0.06B 0.19
2019-09-30 $0.01B $0.07B 0.16
2019-06-30 $0.01B $0.04B 0.25
2019-03-31 $0.01B $0.05B 0.23
2018-12-31 $0.01B $0.05B 0.17
2018-09-30 $0.01B $0.06B 0.14
2018-06-30 $0.01B $0.06B 0.14
2018-03-31 $0.01B $0.06B 0.12
2017-12-31 $0.01B $0.07B 0.12
2017-09-30 $0.01B $0.08B 0.11
2017-06-30 $0.01B $0.08B 0.10
2017-03-31 $0.01B $0.08B 0.10
2016-12-31 $0.01B $0.09B 0.10
2016-09-30 $0.01B $0.09B 0.09
2016-06-30 $0.01B $0.10B 0.08
2016-03-31 $0.01B $0.10B 0.08
2015-12-31 $0.01B $0.10B 0.09
2015-09-30 $0.01B $0.11B 0.08
2015-06-30 $0.01B $0.11B 0.09
2015-03-31 $0.01B $0.11B 0.09
2014-12-31 $0.01B $0.12B 0.10
2014-09-30 $0.01B $0.12B 0.08
2014-06-30 $0.01B $0.12B 0.08
2014-03-31 $0.01B $0.12B 0.08
2013-12-31 $0.01B $0.13B 0.10
2013-09-30 $0.01B $0.05B 0.29
2013-06-30 $0.02B $0.05B 0.31
2013-03-31 $0.02B $0.05B 0.30
2012-12-31 $0.02B $0.05B 0.34
2012-09-30 $0.02B $0.05B 0.33
2012-06-30 $0.02B $0.05B 0.35
2012-03-31 $0.02B $0.05B 0.36
2011-12-31 $0.02B $0.05B 0.41
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.025B $0.006B
Evogene is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding of biology and leveraging Big Data and Artificial Intelligence, Evogene established its unique technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. Evogene holds a number of subsidiaries utilizing the CPB platform to develop human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $177.544B 17.76
Vertex Pharmaceuticals (VRTX) United States $125.961B 32.41
Regeneron Pharmaceuticals (REGN) United States $117.597B 28.76
CSL (CSLLY) Australia $100.887B 0.00
Gilead Sciences (GILD) United States $91.583B 18.24
Bristol Myers Squibb (BMY) United States $85.929B 40.37
GSK (GSK) United Kingdom $81.574B 9.74
Moderna (MRNA) United States $46.495B 0.00
Biogen (BIIB) United States $32.796B 15.02
Alnylam Pharmaceuticals (ALNY) United States $29.941B 0.00
Argenex SE (ARGX) Netherlands $27.728B 0.00
BioNTech SE (BNTX) Germany $20.532B 172.74
Illumina (ILMN) United States $18.445B 131.58
Genmab (GMAB) Denmark $18.014B 21.12
BioMarin Pharmaceutical (BMRN) United States $15.825B 61.73
BeiGene (BGNE) Cayman Islands $14.741B 0.00
Incyte (INCY) United States $14.678B 22.70
Sarepta Therapeutics (SRPT) United States $13.591B 1198.17
Bio-Techne Corp (TECH) United States $11.964B 45.19
Insmed (INSM) United States $11.154B 0.00
Legend Biotech (LEGN) United States $10.616B 0.00
QIAGEN (QGEN) Netherlands $9.534B 20.37
Exact Sciences (EXAS) United States $8.776B 0.00
Vaxcyte (PCVX) United States $8.656B 0.00
Roivant Sciences (ROIV) United Kingdom $8.207B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.085B 26.44
Ascendis Pharma (ASND) Denmark $7.950B 0.00
Intra-Cellular Therapies (ITCI) United States $7.912B 0.00
Repligen (RGEN) United States $7.131B 93.16
Blueprint Medicines (BPMC) United States $7.105B 0.00
Halozyme Therapeutics (HALO) United States $6.911B 19.19
Exelixis (EXEL) United States $6.840B 35.25
Zealand Pharma (ZLDPF) Denmark $6.433B 0.00
Cytokinetics (CYTK) United States $5.862B 0.00
Krystal Biotech (KRYS) United States $5.735B 0.00
Viking Therapeutics (VKTX) United States $5.524B 0.00
Nuvalent (NUVL) United States $5.154B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.773B 0.00
Apellis Pharmaceuticals (APLS) United States $4.606B 0.00
Avidity Biosciences (RNA) United States $4.282B 0.00
Alkermes (ALKS) Ireland $4.171B 16.33
Immunovant (IMVT) United States $4.153B 0.00
ImmunityBio (IBRX) United States $4.136B 0.00
Axsome Therapeutics (AXSM) United States $3.901B 0.00
Guardant Health (GH) United States $3.812B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.556B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.344B 0.00
Arcellx (ACLX) United States $3.330B 0.00
Merus (MRUS) Netherlands $3.217B 0.00
Amicus Therapeutics (FOLD) United States $3.155B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.145B 0.00
Twist Bioscience (TWST) United States $3.119B 0.00
IDEAYA Biosciences (IDYA) United States $3.111B 0.00
Denali Therapeutics (DNLI) United States $3.106B 0.00
Biohaven (BHVN) United States $3.065B 0.00
ADMA Biologics Inc (ADMA) United States $3.025B 118.64
Rhythm Pharmaceuticals (RYTM) United States $3.004B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.974B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.876B 0.00
Morphic Holding (MORF) United States $2.821B 0.00
MorphoSys AG (MOR) Germany $2.788B 0.00
Apogee Therapeutics (APGE) United States $2.778B 0.00
Geron (GERN) United States $2.770B 0.00
SpringWorks Therapeutics (SWTX) United States $2.701B 0.00
Kymera Therapeutics (KYMR) United States $2.687B 0.00
Certara (CERT) United States $2.575B 59.30
Intellia Therapeutics (NTLA) United States $2.517B 0.00
Vericel (VCEL) United States $2.490B 0.00
Celldex Therapeutics (CLDX) United States $2.476B 0.00
CG Oncology (CGON) United States $2.447B 0.00
Myriad Genetics (MYGN) United States $2.408B 0.00
Iovance Biotherapeutics (IOVA) United States $2.325B 0.00
Fortrea Holdings (FTRE) United States $2.311B 28.41
Janux Therapeutics (JANX) United States $2.232B 0.00
Bavarian Nordic (BVNRY) Denmark $2.109B 9.18
Novavax (NVAX) United States $2.100B 0.00
Beam Therapeutics (BEAM) United States $2.096B 0.00
Protagonist Therapeutics (PTGX) United States $2.094B 14.64
Rocket Pharmaceuticals (RCKT) United States $2.092B 0.00
NovoCure (NVCR) Jersey $1.989B 0.00
Arvinas (ARVN) United States $1.977B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.973B 0.00
Edgewise Therapeutics (EWTX) United States $1.947B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.944B 0.00
Vera Therapeutics (VERA) United States $1.905B 0.00
NeoGenomics (NEO) United States $1.882B 0.00
Zai Lab (ZLAB) China $1.873B 0.00
Akero Therapeutics (AKRO) United States $1.873B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.855B 14.14
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.825B 0.00
Ligand Pharmaceuticals (LGND) United States $1.781B 29.11
Structure Therapeutics (GPCR) United States $1.767B 0.00
Galapagos (GLPG) Belgium $1.763B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.761B 0.00
Neumora Therapeutics (NMRA) United States $1.753B 0.00
Keros Therapeutics (KROS) United States $1.733B 0.00
Kura Oncology (KURA) United States $1.638B 0.00
MannKind (MNKD) United States $1.558B 190.67
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.501B 0.00
Belite Bio (BLTE) United States $1.450B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.400B 0.00
Vir Biotechnology (VIR) United States $1.391B 0.00
Dynavax Technologies (DVAX) United States $1.364B 173.67
Nurix Therapeutics (NRIX) United States $1.362B 0.00
Arcus Biosciences (RCUS) United States $1.340B 0.00
Sana Biotechnology (SANA) United States $1.314B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.309B 0.00
Gyre Therapeutics (GYRE) United States $1.294B 0.00
ANI Pharmaceuticals (ANIP) United States $1.287B 15.98
Prothena (PRTA) Ireland $1.270B 0.00
Spyre Therapeutics (SYRE) United States $1.199B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.157B 0.00
Disc Medicine (IRON) United States $1.142B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.131B 0.00
MiMedx (MDXG) United States $1.076B 45.56
Cullinan Therapeutics (CGEM) United States $1.060B 0.00
Tango Therapeutics (TNGX) United States $1.048B 0.00
Immatics (IMTX) Germany $1.043B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.030B 0.00
Tyra Biosciences (TYRA) United States $1.019B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.966B 0.00
AnaptysBio (ANAB) United States $0.941B 0.00
Praxis Precision Medicines (PRAX) United States $0.925B 0.00
Viridian Therapeutics (VRDN) United States $0.924B 0.00
Humacyte (HUMA) United States $0.921B 0.00
AbCellera Biologics (ABCL) Canada $0.900B 0.00
Liquidia Technologies (LQDA) United States $0.840B 0.00
Cytek Biosciences (CTKB) United States $0.838B 0.00
Cogent Biosciences (COGT) United States $0.837B 0.00
CureVac (CVAC) Germany $0.833B 0.00
Immunome (IMNM) United States $0.822B 0.00
89BIO (ETNB) United States $0.820B 0.00
Rapport Therapeutics (RAPP) $0.815B 0.00
Mesoblast (MESO) Australia $0.811B 0.00
Abivax SA (ABVX) France $0.809B 0.00
Olema Pharmaceuticals (OLMA) United States $0.808B 0.00
Nuvation Bio (NUVB) United States $0.786B 0.00
CARGO Therapeutics (CRGX) United States $0.781B 0.00
Dianthus Therapeutics (DNTH) United States $0.779B 0.00
Pliant Therapeutics (PLRX) United States $0.751B 0.00
Travere Therapeutics (TVTX) United States $0.747B 0.00
Tectonic Therapeutic (TECX) United States $0.734B 0.00
Stoke Therapeutics (STOK) United States $0.710B 0.00
WAVE Life Sciences (WVE) Singapore $0.702B 0.00
Scholar Rock Holding (SRRK) United States $0.698B 0.00
Arbutus Biopharma (ABUS) United States $0.696B 0.00
Zymeworks (ZYME) United States $0.694B 0.00
Oric Pharmaceuticals (ORIC) United States $0.689B 0.00
Mineralys Therapeutics (MLYS) United States $0.676B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.670B 0.00
Prime Medicine (PRME) United States $0.669B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.654B 0.00
ACELYRIN, INC (SLRN) United States $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
ArriVent BioPharma (AVBP) United States $0.643B 0.00
Allogene Therapeutics (ALLO) United States $0.637B 0.00
REGENXBIO (RGNX) United States $0.633B 0.00
IGM Biosciences (IGMS) United States $0.632B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.631B 0.00
Adaptive Biotechnologies (ADPT) United States $0.623B 0.00
Celcuity (CELC) United States $0.620B 0.00
Replimune (REPL) United States $0.618B 0.00
Astria Therapeutics (ATXS) United States $0.607B 0.00
GH Research (GHRS) Ireland $0.606B 0.00
Avid Bioservices (CDMO) United States $0.604B 0.00
Applied Therapeutics (APLT) United States $0.601B 0.00
Emergent Biosolutions (EBS) United States $0.599B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.592B 0.00
Pharming Group (PHAR) Netherlands $0.591B 0.00
ITeos Therapeutics (ITOS) United States $0.589B 0.00
Alumis (ALMS) United States $0.583B 0.00
Entrada Therapeutics (TRDA) United States $0.570B 26.79
Terns Pharmaceuticals (TERN) United States $0.562B 0.00
Alector (ALEC) United States $0.562B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.557B 0.00
Pharming Group (PHGUF) Netherlands $0.555B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.544B 0.00
Contineum Therapeutics (CTNM) United States $0.541B 0.00
PepGen (PEPG) United States $0.539B 0.00
PureTech Health (PRTC) United States $0.538B 0.00
Neurogene (NGNE) United States $0.538B 0.00
GRAIL (GRAL) United States $0.525B 0.00
Erasca (ERAS) United States $0.524B 0.00
Castle Biosciences (CSTL) United States $0.523B 0.00
Annexon (ANNX) United States $0.517B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.515B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.513B 0.00
Fulcrum Therapeutics (FULC) United States $0.505B 0.00
Third Harmonic Bio (THRD) United States $0.492B 0.00
Fate Therapeutics (FATE) United States $0.491B 0.00
MaxCyte (MXCT) United States $0.485B 0.00
Anavex Life Sciences (AVXL) United States $0.483B 0.00
Northwest Biotherapeutics (NWBO) United States $0.481B 0.00
Oculis Holding AG (OCS) Switzerland $0.475B 0.00
Absci (ABSI) United States $0.465B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.461B 0.00
Voyager Therapeutics (VYGR) United States $0.459B 0.00
Kyverna Therapeutics (KYTX) United States $0.452B 0.00
Aura Biosciences (AURA) United States $0.437B 0.00
Editas Medicine (EDIT) United States $0.436B 0.00
C4 Therapeutics (CCCC) United States $0.430B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.428B 0.00
Ocugen (OCGN) United States $0.421B 0.00
Precigen (PGEN) United States $0.419B 0.00
Alto Neuroscience (ANRO) United States $0.413B 0.00
Anika Therapeutics (ANIK) United States $0.409B 350.75
EnGene Holdings (ENGN) United States $0.395B 0.00
Urogen Pharma (URGN) United States $0.390B 0.00
Revance Therapeutics (RVNC) United States $0.381B 0.00
UniQure (QURE) Netherlands $0.379B 0.00
TScan Therapeutics (TCRX) United States $0.366B 0.00
AC Immune (ACIU) Switzerland $0.359B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.353B 0.00
Scilex Holding (SCLX) United States $0.348B 0.00
Q32 Bio (QTTB) United States $0.346B 0.00
ALX Oncology Holdings (ALXO) United States $0.344B 0.00
Cabaletta Bio (CABA) United States $0.341B 0.00
Nautilus Biotechnology (NAUT) United States $0.338B 0.00
Kamada (KMDA) Israel $0.335B 25.35
Inozyme Pharma (INZY) United States $0.329B 0.00
Nkarta (NKTX) United States $0.329B 0.00
Amarin (AMRN) Ireland $0.324B 0.00
XOMA Royalty (XOMA) United States $0.319B 0.00
Jasper Therapeutics (JSPR) United States $0.315B 0.00
Poseida Therapeutics (PSTX) United States $0.313B 0.00
Atea Pharmaceuticals (AVIR) United States $0.310B 0.00
Sutro Biopharma (STRO) United States $0.304B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.304B 0.00
MeiraGTx Holdings (MGTX) United States $0.300B 0.00
Solid Biosciences (SLDB) United States $0.299B 0.00
Cartesian Therapeutics (RNAC) United States $0.297B 0.00
Alimera Sciences (ALIM) United States $0.292B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.291B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.287B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.281B 0.00
Inovio Pharmaceuticals (INO) United States $0.269B 0.00
Tenaya Therapeutics (TNYA) United States $0.265B 0.00
Mersana Therapeutics (MRSN) United States $0.263B 0.00
CorMedix Inc (CRMD) United States $0.256B 0.00
Molecular Partners AG (MOLN) Switzerland $0.241B 0.00
Gossamer Bio (GOSS) United States $0.238B 0.00
Codexis (CDXS) United States $0.233B 0.00
23andMe Holding (ME) United States $0.232B 0.00
2seventy Bio (TSVT) United States $0.232B 0.00
Design Therapeutics (DSGN) United States $0.232B 0.00
GENFIT S.A (GNFT) France $0.232B 0.00
Prima BioMed (IMMP) Australia $0.231B 0.00
Zura Bio (ZURA) United States $0.222B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.222B 0.00
Shattuck Labs (STTK) United States $0.221B 0.00
Caribou Biosciences (CRBU) United States $0.217B 0.00
ChromaDex (CDXC) United States $0.208B 0.00
Renovaro (RENB) United States $0.207B 0.00
Abeona Therapeutics (ABEO) United States $0.206B 0.00
XBiotech (XBIT) United States $0.204B 0.00
Greenwich LifeSciences (GLSI) United States $0.200B 0.00
Adverum Biotechnologies (ADVM) United States $0.197B 0.00
Ventyx Biosciences (VTYX) United States $0.194B 0.00
Seres Therapeutics (MCRB) United States $0.191B 0.00
G1 Therapeutics (GTHX) United States $0.190B 0.00
Oncobiologics (OTLK) United States $0.190B 0.00
Inhibrx Biosciences (INBX) $0.188B 0.00
Generation Bio (GBIO) United States $0.188B 0.00
Trevi Therapeutics (TRVI) United States $0.187B 0.00
Biomea Fusion (BMEA) United States $0.185B 0.00
Candel Therapeutics (CADL) United States $0.185B 0.00
Coherus BioSciences (CHRS) United States $0.180B 0.00
Puma Biotechnology (PBYI) United States $0.178B 11.21
FibroBiologics (FBLG) United States $0.178B 0.00
Rezolute (RZLT) United States $0.177B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.176B 0.00
Innate Pharma S.A (IPHA) France $0.175B 0.00
Adocia (ADOCY) France $0.174B 0.00
Adherex Technologies (FENC) United States $0.173B 211.33
Rani Therapeutics Holdings (RANI) United States $0.170B 0.00
INmune Bio (INMB) United States $0.169B 0.00
Skye Bioscience (SKYE) United States $0.167B 0.00
Repare Therapeutics (RPTX) Canada $0.167B 0.00
Compugen (CGEN) Israel $0.162B 0.00
Syros Pharmaceuticals (SYRS) United States $0.162B 0.00
ScPharmaceuticals (SCPH) United States $0.162B 0.00
Kodiak Sciences (KOD) United States $0.158B 0.00
BioStem Technologies (BSEM) $0.156B 0.00
Lifecore Biomedical (LFCR) United States $0.154B 0.00
Agenus (AGEN) United States $0.153B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.146B 0.00
Elevation Oncology (ELEV) United States $0.146B 0.00
Invivyd (IVVD) United States $0.146B 0.00
Vigil Neuroscience (VIGL) United States $0.142B 0.00
PDS Biotechnology (PDSB) United States $0.142B 0.00
DiaMedica Therapeutics (DMAC) United States $0.139B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.134B 0.00
Inventiva S.A (IVA) France $0.133B 0.00
Compass Therapeutics (CMPX) United States $0.132B 0.00
Semper Paratus Acquisition (TVGN) United States $0.129B 0.00
Annovis Bio (ANVS) United States $0.127B 0.00
Adlai Nortye (ANL) Cayman Islands $0.126B 0.00
Bluebird Bio (BLUE) United States $0.126B 0.00
X4 Pharmaceuticals (XFOR) United States $0.126B 0.00
Immunic (IMUX) United States $0.123B 0.00
Athira Pharma (ATHA) United States $0.123B 0.00
Opthea (OPT) Australia $0.121B 0.00
Werewolf Therapeutics (HOWL) United States $0.120B 0.00
Cellectis S.A (CLLS) France $0.120B 0.00
Rapt Therapeutics (RAPT) United States $0.120B 0.00
I-Mab (IMAB) China $0.120B 0.00
Nuvectis Pharma (NVCT) United States $0.120B 0.00
Akoya Biosciences (AKYA) United States $0.119B 0.00
Seer (SEER) United States $0.117B 0.00
Adagene (ADAG) China $0.113B 0.00
ATyr Pharma (ATYR) United States $0.113B 0.00
TELA Bio (TELA) United States $0.112B 0.00
CytomX Therapeutics (CTMX) United States $0.106B 6.80
Cardiff Oncology (CRDF) United States $0.106B 0.00
CervoMed (CRVO) United States $0.102B 0.00
Coya Therapeutics (COYA) United States $0.102B 0.00
Omega Therapeutics (OMGA) United States $0.101B 0.00
Adicet Bio (ACET) United States $0.101B 0.00
BioHarvest Sciences (CNVCF) Canada $0.101B 0.00
VistaGen Therapeutics (VTGN) United States $0.100B 0.00
Sagimet Biosciences (SGMT) United States $0.098B 0.00
Elutia (ELUT) United States $0.097B 0.00
InflaRx (IFRX) Germany $0.094B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.093B 0.00
HilleVax (HLVX) United States $0.092B 0.00
Checkpoint Therapeutics (CKPT) United States $0.092B 0.00
IO Biotech (IOBT) Denmark $0.091B 0.00
Benitec Biopharma (BNTC) United States $0.090B 0.00
BeyondSpring (BYSI) United States $0.090B 0.00
Eton Pharmaceuticals (ETON) United States $0.088B 85.50
Tiziana Life Sciences (TLSA) United Kingdom $0.088B 0.00
Boundless Bio (BOLD) United States $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.086B 0.00
BioAtla (BCAB) United States $0.086B 0.00
AN2 Therapeutics (ANTX) United States $0.085B 0.00
Genenta Science S.p.A (GNTA) Italy $0.084B 0.00
Sangamo Therapeutics (SGMO) United States $0.084B 0.00
Verastem (VSTM) United States $0.083B 0.00
Affimed (AFMD) Germany $0.083B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.083B 0.00
Instil Bio (TIL) United States $0.082B 0.00
Chimerix (CMRX) United States $0.081B 0.00
Ikena Oncology (IKNA) United States $0.081B 0.00
DBV Technologies S.A (DBVT) France $0.080B 0.00
Kronos Bio (KRON) United States $0.079B 0.00
Genelux (GNLX) United States $0.079B 0.00
LENZ Therapeutics (LENZ) United States $0.079B 0.00
Oncolytics Biotech (ONCY) Canada $0.079B 0.00
Cognition Therapeutics (CGTX) United States $0.078B 0.00
Alpha Teknova (TKNO) United States $0.078B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.78
Gritstone Bio (GRTS) United States $0.076B 0.00
Theratechnologies (THTX) Canada $0.071B 0.00
Connect Biopharma Holdings (CNTB) United States $0.071B 0.00
Precision BioSciences (DTIL) United States $0.069B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.068B 0.00
Ovid Therapeutics (OVID) United States $0.068B 0.00
MediciNova (MNOV) United States $0.068B 0.00
Entera Bio (ENTX) Israel $0.067B 0.00
Intensity Therapeutics (INTS) United States $0.067B 0.00
Allakos (ALLK) United States $0.066B 0.00
VTv Therapeutics (VTVT) United States $0.066B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.066B 0.00
Earth Science Tech (ETST) United States $0.065B 0.00
Eyenovia (EYEN) United States $0.063B 0.00
HOOKIPA Pharma (HOOK) United States $0.063B 0.00
Vor Biopharma (VOR) $0.063B 0.00
Galena Biopharma (SLS) United States $0.062B 0.00
Aileron Therapeutics (ALRN) United States $0.061B 0.00
Celularity (CELU) United States $0.059B 0.00
Enzo Biochem (ENZ) United States $0.058B 0.00
Cidara Therapeutics (CDTX) United States $0.058B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.057B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.057B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.056B 0.00
Passage Bio (PASG) United States $0.055B 0.00
Turnstone Biologics (TSBX) United States $0.055B 0.00
Immix Biopharma (IMMX) United States $0.054B 0.00
Leap Therapeutics (LPTX) United States $0.054B 0.00
Rallybio (RLYB) United States $0.054B 0.00
Aerovate Therapeutics (AVTE) United States $0.052B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.052B 0.00
Atara Biotherapeutics (ATRA) United States $0.051B 0.00
Ocuphire Pharma (OCUP) United States $0.050B 0.00
Estrella Immunopharma (ESLA) United States $0.048B 0.00
Lantern Pharma (LTRN) United States $0.048B 0.00
ARCA Biopharma (ABIO) United States $0.048B 0.00
NextCure (NXTC) United States $0.047B 0.00
Kezar Life Sciences (KZR) United States $0.047B 0.00
BioXcel Therapeutics (BTAI) United States $0.047B 0.00
LakeShore Biopharma (LSB) China $0.047B 0.00
OKYO Pharma (OKYO) $0.046B 0.00
Elicio Therapeutics (ELTX) United States $0.045B 0.00
CalciMedica (CALC) United States $0.045B 0.00
Lexaria Bioscience (LEXX) Canada $0.044B 0.00
Fortress Biotech (FBIO) United States $0.043B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.042B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
Dyadic (DYAI) United States $0.041B 0.00
Cue Biopharma (CUE) United States $0.040B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.040B 0.00
Ocean Biomedical (OCEA) United States $0.040B 0.00
Promis Neurosciences (PMN) Canada $0.040B 0.00
Curis (CRIS) United States $0.039B 0.00
Aligos Therapeutics (ALGS) United States $0.039B 0.00
Aadi Bioscience (AADI) United States $0.038B 0.00
IN8bio (INAB) United States $0.037B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.035B 0.00
Cyclo Therapeutics (CYTH) United States $0.034B 0.00
Xilio Therapeutics (XLO) United States $0.034B 0.00
Immuneering (IMRX) United States $0.034B 0.00
MiNK Therapeutics (INKT) United States $0.033B 0.00
Quince Therapeutics (QNCX) United States $0.032B 0.00
Equillium (EQ) United States $0.032B 0.00
Clene (CLNN) United States $0.031B 0.00
Pluri (PLUR) Israel $0.030B 0.00
Lisata Therapeutics (LSTA) United States $0.029B 0.00
BioAffinity Technologies (BIAF) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
NKGen Biotech (NKGN) United States $0.029B 0.00
RenovoRx (RNXT) United States $0.029B 0.00
Bolt Biotherapeutics (BOLT) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.026B 0.00
SAB Biotherapeutics (SABS) United States $0.026B 0.00
HCW Biologics (HCWB) United States $0.025B 0.00
Biora Therapeutics (BIOR) United States $0.025B 0.00
Beyond Air (XAIR) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.025B 0.00
Carmell (CTCX) United States $0.024B 0.00
Orgenesis (ORGS) United States $0.024B 0.00
Cocrystal Pharma (COCP) United States $0.024B 0.00
Spruce Biosciences (SPRB) United States $0.022B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
Aprea Therapeutics (APRE) United States $0.022B 0.00
Longeveron (LGVN) United States $0.021B 0.00
Apollomics (APLM) United States $0.021B 0.00
Forte Biosciences (FBRX) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.019B 0.00
KALA BIO (KALA) United States $0.019B 0.00
Cara Therapeutics (CARA) United States $0.019B 0.00
VBI Vaccines (VBIV) United States $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
Sensei Biotherapeutics (SNSE) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Galecto (GLTO) Denmark $0.016B 0.00
Evaxion Biotech (EVAX) Denmark $0.016B 0.00
IMMURON (IMRN) Australia $0.015B 0.00
Kintara Therapeutics (KTRA) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
BRIACELL THERAP (BCTX) Canada $0.014B 0.00
Imunon (IMNN) United States $0.013B 0.00
Silo Pharma (SILO) United States $0.013B 0.00
Monopar Therapeutics (MNPR) United States $0.013B 0.00
Chemomab Therapeutics (CMMB) Israel $0.012B 0.00
Vaccinex (VCNX) United States $0.012B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.012B 0.00
Aptose Biosciences (APTO) Canada $0.012B 0.00
Lumos Pharma (LUMO) United States $0.012B 0.00
Senti Biosciences (SNTI) United States $0.012B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.011B 0.00
AEterna Zentaris (AEZS) Canada $0.011B 0.00
Moleculin Biotech (MBRX) United States $0.011B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.010B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.010B 0.00
ABVC BioPharma (ABVC) United States $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
Purple Biotech (PPBT) Israel $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Organovo Holdings (ONVO) United States $0.009B 0.00
Kineta (KA) United States $0.009B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
ANEW Medical (WENA) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Telesis Bio (TBIO) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Bionomics (BNOX) Australia $0.007B 0.00
GeoVax Labs (GOVX) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.006B 0.00
Notable Labs (NTBL) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Trevena (TRVN) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Psyence Biomedical (PBM) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
Portage Biotech (PRTG) $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
Cingulate (CING) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00